According to new research from the Monell Center and collaborating institutions, odors from human skin cells can be used to identify melanoma, the deadliest form of skin cancer.
In addition to detecting a unique odor signature associated with melanoma cells, the researchers also demonstrated that a nanotechnology-based sensor could reliably differentiate melanoma cells from normal skin cells. The findings suggest that non-invasive odor analysis may be a valuable technique in the detection and early diagnosis of human melanoma.
Melanoma is a tumor affecting melanocytes, skin cells that produce the dark pigment that gives skin its color. The disease is responsible for approximately 75 percent of skin cancer deaths, with chances of survival directly related to how early the cancer is detected. Current detection methods most commonly rely on visual inspection of the skin, which is highly dependent on individual self-examination and clinical skill.
The current study took advantage of the fact that human skin produces numerous airborne chemical molecules known as volatile organic compounds, or VOCs, many of which are odorous. “There is a potential wealth of information waiting to be extracted from examination of VOCs associated with various diseases, including cancers, genetic disorders, and viral or bacterial infections,” notes George Preti, PhD, an organic chemist at Monell who is one of the paper’s senior authors.
In the study, published online ahead of print in the Journal of Chromatography B, researchers used sophisticated sampling and analytical techniques to identify VOCs from melanoma cells at three stages of the disease as well as from normal melanocytes. All the cells were grown in culture.
The researchers used an absorbent device to collect chemical compounds from air in closed containers containing the various types of cells. Then, gas chromatography-mass spectrometry techniques were used to analyze the compounds and identified different profiles of VOCs emitting from melanoma cells relative to normal cells.
Both the types and concentrations of chemicals were affected. Melanoma cells produced certain compounds not detected in VOCs from normal melanocytes and also more or less of other chemicals. Further, the different types of melanoma cells could be distinguished from one another.
Noting that translation of these results into the clinical diagnostic realm would require a reliable and portable sensor device, the researchers went on to examine VOCs from normal melanocytes and melanoma cells using a previously described nano-sensor.
Constructed of nano-sized carbon tubes coated with strands of DNA, the tiny sensors can be bioengineered to recognize a wide variety of targets, including specific odor molecules. The nano-sensor was able to distinguish differences in VOCs from normal and several different types of melanoma cells.
“We are excited to see that the DNA-carbon nanotube vapor sensor concept has potential for use as a diagnostic. Our plan is to move forward with research into skin cancer and other diseases,” said A.T. Charlie Johnson, PhD, Professor of Physics at the University of Pennsylvania, who led the development of the olfactory sensor.
Together, the findings provide proof-of-concept regarding the potential of the two analytical techniques to identify and detect biomarkers that distinguish normal melanocytes from different melanoma cell types.
“This study demonstrates the usefulness of examining VOCs from diseases for rapid and noninvasive diagnostic purposes,” said Preti. “The methodology should also allow us to differentiate stages of the disease process.”
Current studies are focusing on analysis of VOCs from tumor sites of patients diagnosed with primary melanoma.
The Latest Bing News on:
- Practice-Changing Results in Metastatic Uveal Melanomaon April 10, 2021 at 12:00 pm
A novel bispecific protein significantly improved overall survival (OS) in metastatic uveal melanoma as compared with investigator's choice of treatment, including checkpoint inhibitors, a randomized ...
- Freenome Presents Data Revealing Signatures of Immune Checkpoint Inhibitor Treatment Response Found to Be Common Across Kidney, Melanoma, and Lung Cancerson April 10, 2021 at 9:30 am
Plasma samples from patients with kidney (n=21), melanoma (n=14) or non-small cell lung cancer (n=91) revealed signatures of immune checkpoint inhibition treatment response found to be common across ...
- Iovance Biotherapeutics Announces Clinical Data Updates for Lifileucel in Advanced Melanoma ...on April 9, 2021 at 4:01 am
Median Duration of Response Not Reached at 28.1 Months of Median Study Follow Up in Cohort 2 of C-144-01 Study 36.4% Overall Response Rate; Continued Deepening of Responses SAN CARLOS, Calif., April ...
- Increased incidence of melanoma in Utah points to overdiagnosison April 8, 2021 at 9:36 pm
A letter published today by Huntsman Cancer Institute (HCI) at the University of Utah (U of U) in the New England Journal of Medicine reports that melanoma mortality among Utahns outpaced that of the ...
- More Melanoma, Less Prostate Cancer; Aggressive End-of-Life Care; J&J Has Friendson April 8, 2021 at 2:01 pm
New projections for cancer trends over the next 2 decades suggest that the incidence of melanoma will continue to increase, and that there will be more deaths from pancreatic and liver cancers, fewer ...
- STING gene methylation allows melanoma to evade the immune systemon April 8, 2021 at 2:00 pm
Researchers demonstrate how an important defect in STING gene expression in melanoma cells contributes to their evasion from immune cell detection and destruction.
- Investigators identify STING gene methylation allows melanoma to evade the immune systemon April 8, 2021 at 11:25 am
A dysfunctional immune system significantly contributes to the development of cancer. Several therapeutic strategies to activate the immune system to target cancer cells have been approved to treat ...
- CSDE1 attenuates microRNA-mediated silencing of PMEPA1 in melanomaon April 8, 2021 at 8:39 am
CSDE1 is an RBP that promotes metastasis in melanoma and mechanisms underlying its oncogenic activities need to be completely defined. Here we report that CSDE1 interacts with specific miRNA-induced ...
- Olig2 regulates p53-mediated apoptosis, migration and invasion of melanoma cellson April 8, 2021 at 6:46 am
Melanoma is a disease with a high recurrence rate and poor prognosis; therefore, the need for targeted therapeutics is steadily increasing. Oligodendrocyte transcription factor2 (Olig2) is a basic ...
- Study indicates an amyloid link between melanoma and Parkinson’s diseaseon April 7, 2021 at 5:36 am
On the surface, Parkinson's disease -; a neurodegenerative disorder -; and melanoma -; a type of skin cancer -; do not appear to have much in common.
The Latest Google Headlines on:
The Latest Bing News on:
- Hixson Man Has Jeep Hit By Train; He Winds Up In Jailon March 21, 2021 at 4:59 pm
He had bloody, watery red eyes. Gudell agreed to a breathalyzer test, but kept putting his tongue in the way so there could not be a reading. He was taken on to jail and given a blood test there.
- Roy Exum: He’s Exempt From Drunkon March 20, 2021 at 5:00 pm
When the lawmaker was hauled to the Frankfort jail, he refused to repeat the test on the official breathalyzer. Nonetheless, he was arrested for driving under the influence. This is where it gets ...